Cargando…
Novel Curcumin Derivative-Decorated Ultralong-Circulating Paclitaxel Nanoparticles: A Novel Delivery System with Superior Anticancer Efficacy and Safety
PURPOSE: Paclitaxel (PTX) has been widely utilized for the treatment of breast cancer. However, drawbacks, such as poor aqueous solubility, rapid blood clearance and severe toxicity, greatly reduce its efficacy and safety. Herein, a novel self-developed curcumin derivative (CUD) was chosen as the ca...
Autores principales: | Wei, Yumeng, Zeng, Mingtang, Pi, Chao, Shen, Hongping, Yuan, Jiyuan, Zuo, Ying, Wen, Jie, Guo, Pu, Zhao, Wenmei, Li, Ke, Su, Zhilian, Song, Xinjie, Fu, Shaozhi, Lee, Robert J, Zhao, Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673813/ https://www.ncbi.nlm.nih.gov/pubmed/36406640 http://dx.doi.org/10.2147/IJN.S369761 |
Ejemplares similares
-
Anti-lung cancer effect of paclitaxel solid lipid nanoparticles delivery system with curcumin as co-loading partner in vitro and in vivo
por: Pi, Chao, et al.
Publicado: (2022) -
The Effects of a Novel Curcumin Derivative Loaded Long-Circulating Solid Lipid Nanoparticle on the MHCC-97H Liver Cancer Cells and Pharmacokinetic Behavior
por: Wei, Yumeng, et al.
Publicado: (2022) -
Formulation of the novel structure curcumin derivative–loaded solid lipid nanoparticles: synthesis, optimization, characterization and anti-tumor activity screening in vitro
por: Li, Ke, et al.
Publicado: (2022) -
Solid lipid nanoparticle as an effective drug delivery system of a novel curcumin derivative: formulation, release in vitro and pharmacokinetics in vivo
por: Zhao, Wenmei, et al.
Publicado: (2022) -
Patient-Derived Xenograft: A More Standard “Avatar” Model in Preclinical Studies of Gastric Cancer
por: Zeng, Mingtang, et al.
Publicado: (2022)